Key result
Despite a number of clinical trials in post-polio syndrome, no effective disease-modifying pharmacological treatments are currently available, and therapy centers on symptomatic relief.
Why the study?
Despite its high prevalence, post-polio syndrome etiology remains elusive, progression mechanisms are poorly understood, and the condition is under-researched, particularly regarding non-motor symptoms.
Post-polio syndrome is a complex neurological condition with both motor and non-motor symptoms that currently lacks effective disease-modifying pharmacological treatments.
No takes yet. Share an insight, caveat, or question.
Symptomatic management remains standard for post-polio syndrome; leaves open targeted trials for disease-modifying therapies.
Shing et al. (2019) conducted a review in Post-polio syndrome. Pharmacological and non-pharmacological treatments was evaluated. Despite a number of clinical trials in post-polio syndrome, no effective disease-modifying pharmacological treatments are currently available, and therapy centers on symptomatic relief.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: